Clinical Trials Directory

Trials / Completed

CompletedNCT02749786

Genetic Basis of Rosacea Study (Control)

Expansion Arm of Papulopustular Rosacea Gene Expression Profiling to Include Normal Individuals as Anatomic Site Specific Controls

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. It it considered to be a syndrome encompassing various combinations of cutaneous signs including flushing, erythema, telangiectasia, papules, edema, ocular lesions, and rhinophyma. The exact etiology of cutaneous rosacea is unknown but is characterized by persistent vasodilation, increased vascular permeability, and vascular hyper-reactivity of the microcirculation of the central part of the face. The purpose of this study is to develop gene expression profiles of papulopustular rosacea compared to those of normal skin. The investigator hopes to better understand the abnormal gene functions that might contribute to this condition. This understanding may lead to the development of additional and better treatments for rosacea.

Conditions

Interventions

TypeNameDescription
OTHERSkin BiopsySkin biopsies will be performed via the Keys punch technique from normal facial skin.

Timeline

Start date
2016-01-21
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2016-04-25
Last updated
2019-09-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02749786. Inclusion in this directory is not an endorsement.